Exosome Skincare Manufacturer

Moe’s Group is a private-label skincare manufacturer in Chatsworth, California that develops and produces cosmetic formulas made with exosome-derived ingredients. We handle formulation, filling, labelling and packaging under private label, white label and fully custom development, from research through to production. This is a contract manufacturer’s hub for the category, and it includes the part most exosome marketing leaves out: exosomes are the most compliance-sensitive ingredient in skincare right now, and a cosmetic made with them is a very different thing from the clinical products the headlines describe.

Who manufactures exosome skincare in the USA?

Moe’s Group does, at our own facility in Chatsworth, California. We are a private-label and custom-formulation cosmetics manufacturer, and we help brands develop finished cosmetics made with exosome-derived ingredients, handling formulation, filling, labelling and packaging under one roof. A brand can arrive with a concept and leave with a shelf-ready product formulated to spec, developed from research through to production without switching partners along the way.

What are exosomes in skincare?

Exosomes are microscopic extracellular vesicles that carry signalling molecules between cells. In the cosmetic context they are used as ingredients marketed around skin renewal and a healthy-looking, more resilient complexion. It is worth being precise about a distinction the marketing tends to blur: the exosome materials realistically available for a retail cosmetic are plant-, marine- or ferment-derived and are best described as exosome-inspired, and they are formulated to speak to how skin looks and feels. That is not the same as the human-cell-derived exosomes used in clinics, which sit in an entirely different regulatory category. We build the cosmetic.

Can Moe’s Group manufacture exosome products under private label?

Yes. We formulate, fill and label exosome cosmetics under private label, white label or fully custom formulation, in serum, ampoule, essence, cream and mask formats. Our chemists develop to a brand’s chosen ingredient source, concentration and format, and we support new brands launching a first product as readily as established ranges adding one. Brands set their own MOQs and timelines.

Where do the exosome ingredients come from?

We source cosmetic ingredients internationally and work with brands on sourcing transparency, because with exosome materials the raw-material specification matters more than in almost any other category. Source, purity and characterisation vary widely between suppliers, so the spec sheet is where the real diligence happens: what the material is derived from, how it is characterised, and what the supplier can and cannot substantiate. We help a brand read that sheet honestly and formulate a stable finished product around it, rather than taking a headline ingredient name at face value.

Are exosomes ready for a retail cosmetic line?

With care, and this is the most useful thing a manufacturer can tell you before you commit a formula. Most of the compelling exosome evidence concerns injected or clinically administered products, not topical cosmetics, and regulators have taken action against unapproved injectable exosome products. A topical cosmetic made with exosome-derived ingredients is a different thing entirely, and it must speak to appearance only. The category has a genuine biotech story and real consumer pull; it does not yet have a settled topical-cosmetic evidence base. A brand can enter it well by being disciplined about claims from the first draft of the label, which is exactly where we start.

What claims can a topical exosome cosmetic make?

Cosmetic ones, about appearance. A topical exosome product sold as a cosmetic in the United States can speak to how skin looks and feels – smoother, firmer-looking, more radiant, a more even-looking tone. It cannot claim to heal, regenerate or repair tissue. That is precisely the language much of the exosome literature is written in, because that literature studies clinical and injectable use, which is what makes this the single biggest compliance trap on the ingredient shelf. Regeneration and tissue repair are drug claims. Keep the claim set cosmetic, and keep the substantiation attached to your finished product rather than to the reputation of the raw material.

How do exosome cosmetics fit alongside peptides and PDRN?

They sit in the same regeneration-story shelf as PDRN and next-generation peptides, and many brands weigh all three when they plan a “skin longevity” range. The honest ranking on evidence is roughly the reverse of the hype: peptides have the most settled cosmetic evidence of the three, PDRN’s strong data is largely injectable rather than topical, and exosomes are the most emerging and the most compliance-sensitive. We manufacture across all three, so a brand can build a coherent range and keep every claim on the same cosmetic footing. See our PDRN manufacturing, copper peptide manufacturing and peptide skincare contract manufacturing pages, and our primer on exosomes in skincare.

Is exosome manufacturing done under certified GMP?

Yes. Moe’s Group holds ISO 22716:2007 for cosmetics Good Manufacturing Practices, with skin care, hair care and oils named in the certified scope, alongside ISO 9001:2015 and ISO 45001:2018, and operates an FDA registered facility. Certificates are downloadable on our certifications page.

The short version

• What we do: develop, formulate, fill and package cosmetics made with exosome-derived ingredients, in California.
• Sourcing: ingredients sourced internationally, with sourcing transparency – the spec sheet is where the diligence happens.
• The honest angle: most exosome evidence is clinical or injectable; a cosmetic is a different thing and speaks to appearance only.
• Regulators have acted against unapproved injectable exosome products – a compelling reason to keep a cosmetic strictly cosmetic.
• Keep claims cosmetic. Regeneration and tissue repair are drug language; smoother and firmer-looking are not.
• Plan the range together: exosomes alongside PDRN and peptides, all on the same cosmetic footing.

Start an exosome product

Tell us the ingredient source, the format and the volume you have in mind, and our chemists will come back with options and an honest read on what the material can and cannot support in a claim. We develop from research through to production, with filling, labelling and packaging in house. Related reading: our primer on exosomes in skincare, and our PDRN manufacturing and copper peptide manufacturing hubs if you are weighing the regeneration-story ingredients together. Certifications and FDA facility registration are documented on the certifications page. To talk through a formula, use the product inquiry form.